Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study
Author:
Affiliation:
1. Institute for Neurological Sciences, Algesiology and Pediatrics NuernbergGermany
2. Schmerz- und Palliativzentrum Göppingen GöppingenGermany
3. AWD.pharma/CT Arzneimittel, Medical Development RadebeulGermany
Publisher
Informa Healthcare
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1185/03007995.2012.726216
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Predictors of success of pharmacological management in patients with chronic lower back pain: systematic review;Journal of Orthopaedic Surgery and Research;2024-04-18
2. Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials;BMJ Open;2024-01
3. Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain;BMC Musculoskeletal Disorders;2023-05-30
4. Benefits and harms of treatments for chronic nonspecific low back pain without radiculopathy: systematic review and meta-analysis;The Spine Journal;2023-05
5. Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K V 7 channel openers: Exploration of a nicotinamide scaffold;Archiv der Pharmazie;2022-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3